Business Wire: Ocular Therapeutix™ Announces Phase 3 Clinical Development Plan for OTX-TP, an Innovative Therapy for Glaucoma and Ocular Hypertension Ocular Therapeutix™ Announces Phase 3 Clinical Development Plan for OTX-TP, an Innovative Therapy for Glaucoma and Ocular Hypertension Nature: The impact of available anti-glaucoma therapy on the volume and age profile of patients undergoing glaucoma filtration surgery The impact of available anti-glaucoma therapy on the volume and age profile of patients undergoing glaucoma filtration surgery